Vincerx Pharma (VINC)
(Delayed Data from NSDQ)
$0.65 USD
-0.03 (-4.43%)
Updated Jul 29, 2024 03:59 PM ET
After-Market: $0.64 -0.01 (-1.52%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.17 | 0.00% |
Earnings Summary
For their last quarter, Vincerx Pharma (VINC) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.26 per share. This reflects a negative earnings surprise of 30.77%. Look out for VINC's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.17 per share, reflecting a year-over-year increase of 67.31%.
Earnings History
Price & Consensus
Zacks News for VINC
Vincerx (VINC) Tumbles on Results From Cancer Therapy Study
VINC: What are Zacks experts saying now?
Zacks Private Portfolio Services